Pneumonia during Mechanical Ventilation

Anesteziologie a Intenzivni Medicina

Volumn 15, Issue 2, 2004, Pages 89-100

  Van Saene, H K F ^a   Peric, M ^b   De La Cal, M A ^c   Silvestri, L ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d Ospedale Civile di Gorizia   (Italy)

Author keywords

Diagnosis; Pathogenesis; Pneumonia; Potentially pathogenic micro organisms; Ventilation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFRADINE; COLISTIN; GENTAMICIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BACTERIAL FLORA; BACTERIUM CARRIER; BACTERIUM CULTURE; BODY POSITION; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG CONTRAINDICATION; ERADICATION THERAPY; GRAM NEGATIVE BACTERIUM; HUMAN; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; PERSONAL HYGIENE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 1642366223     PISSN: 12142158     EISSN: 18054412     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. European Task Force on ventilator-associated pneumonia. Ventilator-associated pneumonia. Eur Resp J, 2001; 17: 1034-1045.
2. Cook, D. Ventilator-associated pneumonia: perspectives on the burden of illness. Intensive Care Med 2000; 26 Suppl 1: p. S31-S37.
3. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256.
4. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care patients in a suburban medical center. Crit Care Med 2003; 31: 1312-1317.
5. van Saene HKF, Damjanovic V, Alcock SR. Basics in microbiology for the patient requiring intensive care. Curr Anaesth Crit Care 2001; 12: 6-17.
6. Austrian R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986; 18 (Suppl A): 35-45.
7. Moxon ER. The carrier state: Haemophilus influenzae. J Antimicrob Chemother, 1986; 18 (Suppl A): 17-24.
8. van Eechoutte M, Verschraegen G, Claeys G, et al. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990; 28: 2674-2680.
9. Buck AC, Cooke EM. The fate of ingested Pseudomonas aeruginosa in normal persons. J Med Microbiol 1969; 2: 521-525.
10. Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71.
11. Kleinegger CL, Lockhart SR, Vargas K, Soll DR. Frequency, intensity, species, and strains of oral Candida vary as a function of host age. J Clin Microbiol 1996; 34: 2246-2254.
12. Bauer TT, Torres A. Candida pneumonia. Clin Intens Care 1999; 10: 33-39.
13. Mackowiak PA, Martin RM, Jones SR, et al. Pharyngeal colonisation by Gram-negative bacilli in aspiration prone persons. Arch Int Med 1978; 138: 1224-1227.
14. Fuxench-Lopez Z, Ramirez-Ronda CH. Pharyngeal flora in ambulatory alcoholic patients. Prevalence of Gram-negative bacilli. Arch Int Med 1978; 138: 1815-1816.
15. Mobbs KJ, van Saene HKF, Sunderland D, Davies PDO. Oropharyngeal Gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease. Respir Med 1999; 93: 540-545.
16. Gilman RH, Brown KH, Gilman JB, et al. Colonization of the oropharynx with Gram-negative bacilli in children with severe protein - calorie malnutrition. Am J Clin Nutr 1982; 36: 284-289.
17. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, et al. Prevention of colonization and infection in critically ill patients: a prospective randomised study. Crit Care Med 1988; 16: 1087-1093.
18. Sanchez-Garcia M, Cambronero-Galache JA, Lopez Diaz J. et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. Am J Respir Crit Care Med 1998; 158: 908-916.
19. Garrouste-Orgeas M, Marie O, Rouveau M, et al. Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infection and mortality. J Hosp Infect 1996; 34:279-289.
20. van Saene HKF, Weir WI, de la Cal MA, et al. Managing MRSA - time for a more pragmatic approach? J Hosp Infect 2004; March issue.
21. Cardenosa Cendrero JA, Solé-Violán J, Bordes Benitez A, et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 1999; 116: 462-470.
22. Silvestri L, Monti-Bragadin C, Milanese M, et al. Are most ICU-infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 1999; 42: 125-133.
23. de la Cal MA, Cerda E, Garcia-Hierro P, et al. Pneumonia in patients with severe burns. A classification according to the concept of the carrier state. Chest 2001; 119: 1160-1165.
24. Thülig B, Hartenauer U, Lawin P. Selective decontamination of the digestive tract in intensive care. Lancet 1992; 340: 604-606.
25. Morar P, Singh V, Makura Z, et al. Differing pathways of lower airway colonization and infection according to mode of ventilation, endotracheal vs tracheotomy. Arch Otolaryng Head Neck Surg 2002; 128: 1061-1066.
26. st ed 1994; 579-594.
27. Garrouste-Orgeas M, Chevret S, Arlet C, et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997; 156:1647-1655.
28. van Uffelen R, van Saene HKF, Fidler V, Lowenberg A. Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation. Intensive Care Med 1984; 10: 233-237.
29. Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med 1994; 150:565-569.
30. Fagon JY, Chastre J, Wolff M, et al. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. A randomised trial. Ann Intern Med 2000; 132:621-630.
31. Ruiz M, Torres A, Ewig S, et al. Non-invasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000; 162: 119-125.
32. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastro-intestinal bleeding in patients requiring mechanical ventilation. New Engl J Med 1998; 338: 791-797.
33. Silvestri L, Sarginson RE, Hughes J, et al. Most nosocomial pneumonias are not due to nosocomial bacteria in ventilated patients. Evaluation of the accuracy of the 48 h time cut-off using carriage as the gold standard. Anaesth Intensive Care 2002;30:275-282.
34. Sarginson RE, Taylor N, Reilly N, et al. Infection in prolonged pediatric critical illness: a prospective four year study based on knowledge of the carrier state. Crit Care Med 2004; in press.
35. Murray AE, Chambers JJ, van Saene HKF. Infections in patients requiring ventilation in intensive care: application of a new classification. Clin Microbiol Infect 1998; 4: 94-99.
36. Petros AJ, O'Connell M, Roberts C, et al. Systemic antimicrobials fail to clear multi-resistant Klebsiella from a pediatric intensive care unit. Chest 2001; 119: 852-866.
37. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992; 18: 20-25.
38. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122: 179-186.
39. Kollef MH, Skubas NJ, Sundt TM. A randomised clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999; 116: 1339-1346.
40. Smulders K, van der Hoeven H, Weers-Pothoff I, et al. A randomised clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 2002; 121: 858-862.
41. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354:1851-1858.
42. van Nieuwenhoven CA, van Tiel FH, Vandenbroucke-Grauls C, et al. The effect of semi-recumbent position on development of ventilator-associated pneumonia (VAP). Intensive Care Med 2002; 27 (Suppl 2): S285: Abstract no 585.
43. van Saene HKF, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 2003; 29: 677-690.
44. Alvarez-Lerma F and the ICU-acquired pneumonia group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22: 387-394.
45. Abele-Horn M, Dauber A, Bauernfeind A, et al. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med 1997; 23: 187-195.
46. Aerdts SJ, van Dalen R, Clasener HA, Festen J, van Lier HJ, Vollaard EJ. Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen. Chest 1991; 100: 763-791.
47. Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996; 22: 997-1003.
48. Barret JP, Jeschke MG, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Bums 2001; 27: 439-445.
49. Bergmans DC, Bonten MJ, Gaillard CA, Paling JC, van der Geest S, van Tiel FH, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001; 164: 382-388.
50. Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 1994; 22: 40-49.
51. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991; 110: 303-309.
52. Boland JP, Sadler DL, Stewart W, Wood DJ, Zerick W, Snodgras KR. Reduction of nosocomial respiratory infections in multiple trauma patients requiring mechanical ventilation by selective parenteral and enteral antisepsis regimen (SPEAR) in the intensive care. Seventeenth international congress of chemotherapy Berlin [1991], abstract no 0465.
53. Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, et al. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 2002; 30: 38-43.
54. Brun-Buisson C, Legrand P, Rauss A, Montravers F, Besbes M, Meakins JL, et al. Intestinal decontamination for control of nosocomial multi-resistant gram-negative bacilli. Ann Intern Med 1989; 110: 873-881.
55. de la Cal MA, Cerda E, Garcia-Hierro P, et al. Survival benefit in severely burned patients receiving selective decontamination of the digestive tract: a randomized, double blind, placebo controlled trial. Med Intens 2002; 26: 152: Abstract 028 bis.
56. Cerra FB, Madadus MA, Dunn DL, Wells CL, Konstantinides NN, Lehman SL, et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992; 127: 163-169.
57. Cockerill FR, III, Muller SR, Anhalt JP, Marsh HM, Farnell MB, Mucha P, et al. Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med 1992; 117: 545-553.
58. Ferrer M, Torres A, Gonzalez J, de la Bellacasa JP, El-Ebiary M, Roca M. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994; 120: 389-395.
59. Finch RG, Tomlinson P, Holliday M, Sole K, Stack C, Rocker G. Selective decontamination of the digestive tract (SDD) in the prevention of secondary sepsis in a medical/surgical intensive care unit. Seventeenth international congress of chemotherapy Berlin 1991 [abstract no 0471].
60. Flaherty J, Nathan C, Kabins SA, Weinstein RA. Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis 1990; 162: 1393-1397.
61. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N Engl J Med 1992; 326: 594-599.
62. Gaussorgues P, Salord F, Sirodot M, Tigaud S, Cagnin S, Gerard M, et al. Efficacité de la décontamination digestive sur la survenue des bactériémies nosocomiales chez les patients sous ventilation méchanique et recevant des betamimétiques. Réanimation Soins Intensifs Médecin d'Urgence 1991; 7: 169-174.
63. Georges B, Mazerolles M, Decun J-F, Rouge P, Pomies S, Cougot P, et al. Décontamination digestive sélective résultats d'une étude chez polytraumatisés. Réanimiation Urgence 1994; 3: 621-627.
64. Hammond JM, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992; 340: 5-9.
65. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002; 73: 1904-1909.
66. Jacobs S, Foweraker JE, Roberts SE. Effectiveness of selective decontamination of the digestive tract (SDD) in an ICU with a policy encouraging a low gastric pH. Clin Intensive Care 1992; 3: 52-58.
67. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PPM, Vroom MB, Dankert J, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362: 1011-1016.
68. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, Hulstaert PF, Vos A, Verhoef J, et al. Prevention of colonization and infection in critically ill patients: a prospective randomized study. Crit Care Med 1988; 16: 1087-1093.
69. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1993; 21: 1466-1473.
70. Krueger WA, Lenhart FP, Neeser G, Ruckdeschel G, Schreckhase H, Eissner HJ, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002; 166: 1029-1037.
71. Laggner AN, Tryba M, Georgopoulos A, Lenz K, Grimm G, Graninger W, et al. Oropharyngeal decontamination with gentamicin for long-term ventilated patients on stress ulcer prophylaxis with sucralfate? Wien Klin Wochenschr 1994; 106: 15-19.
72. Lingnau W, Berger J, Javorsky F, Lejeune P, Mutz N, Benzer H. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 1997; 42:687-694.
73. Luiten EJT, Hop WCJ, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222: 57-65.
74. Martinez-Pellus AE, Merino P, Bru M, Conejero R, Seller G, Munoz C, et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993; 21: 1684-1691.
75. Martinez-Pellus AE, Merino P, Bru M, Canovas J, Seller G, Sapina J, et al. Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination. Intensive Care Med 1997; 23:1251-1257.
76. Palomar M, Alvarez-Lerma F, Jorda R, Bermejo B, for the Catalan study group of nosocomial pneumonia prevention. Prevention of nosocomial pneumonia in mechanically ventilated patients: selective decontamination versus sucralfate. Clin Intensive Care 1997; 8: 228-235.
77. Pneumatikos I, Koulouras V, Nathanail C, Goe D, Nakos G. Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma. Intensive Care Med 2002; 28: 432-437.
78. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 1991; 265: 2704-2710.
79. Guinio B, Albanese J, Bues-Charbit M, Viviand X, Martin C. Selective decontamination of the digestive tract in multiple trauma patients. A prospective, double-blind, randomized, placebo-controlled study. Chest 1996; 109: 765-772.
80. Rocha LA, Martin MJ, Pita S, Paz J, Seco C, Margusino L, et al. Prevention of nosocomial infections in critically ill patients by selective decontamination of the digestive tract. A randomised, double blind, placebo controlled study. Intensive Care Med 1992; 18: 398-404.
81. Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A, Carrillo A, Garcia J, Leon J, et al. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 1990; 18: 1239-1242.
82. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
83. Rolando N, Wade JJ, Stangou A, Gimson AE, Wendon J, Philpott-Howard J, et al. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg 1996; 2: 8-13.
84. Ruza F, Alvarado F, Herruzo R, Delgado MA, Garcia S, Dorao P, et al. Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Eur J Epidemiol 1998; 14: 719-727.
85. Sanchez GM, Cambornero Galache JA, Lopez DJ, Cerda CE, Rubio BJ, Gomez Aguinaga MA, et al. Effectiveness and cost of selective decontamination of the digestive tract in criticaly ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 1998; 158: 908-916.
86. Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 1997; 225: 172-180.
87. Smith SD, Jackson RJ, Hannakan CJ, Wadowsky RM, Tzakis AG, Rowe MI. Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation 1993; 55: 1306-1309.
88. Stoutenbeek CP, van Saene HKF, Zandstra DF. Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. In: Faist EBAE, Schildberg FW, editors. Immune consequences of trauma, shock and sepsis. Lengerich: Pabst Science Publishers 1996: 1055-1066.
89. Stoutenbeek CP, van Saene H, Little RA, Whitehead A. The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients. J Trauma 2004; submitted.
90. Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection. Lancet 1990; 335: 704-707.
91. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Rider VA. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective, randomized study. Intensive Care Med 1989; 15: 424-431.
92. Unertl K, Ruckdeschel G, Selbmann HK, Jensen U, Forst H, Lenhart FP, et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 13: 106-113.
93. Verwaest C, Verhaegen J, Ferdinande P, Schets M, Berghe G, Verbist L. Randomized controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multi-disciplinary intensive care unit. Crit Care Med 1997; 25: 63-71.
94. Wiener J, Itokazu G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind, placebo controlled trial of selective digestive decontamination in a medical, surgical intensive care unit. Clin Infect Dis 1995; 20: 861-867.
95. Winter R, Humphreys H, Pick A, MacGowan AP, Willatts SM, Speller DC. A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 1992; 30: 73-87.
96. Zobel G, Kuttnig M, Grubbauer HM, Semmelrock HJ, Thiel W. Reduction of colonization and infection rate during pediatric intensive care by selective decontamination of the digestive tract. Crit Care Med 1991; 19: 1242-1246.
97. Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Crit Care Med 2002; 30: 1204-1209.
98. Selective Decontamination of the Digestive Tract Trialists Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Br Med J 1993; 307: 525-532.
99. Heyland DK, Cook DJ, Jaescher R, Griffith L, Lee HN, Guyatt GH. Selective decontamination of the digestive tract. An overview. Chest 1994; 105: 1221-1229.
100. Kollef M. The role of selective digestive tract decontamination on mortality and respiratory tract infections. Chest 1994; 105: 1101-1108.
101. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. Br Med J 1998; 316: 1275-1285.
102. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients. A systematic review of the evidence. Arch Surg 1999; 134: 170-176.
103. Redman R, Ludington E, Crocker M, Wittes J, Bellm J, Carlet J and the VAP advisory group. Analysis of respiratory and non-respiratory infections in published trials of selective decontamination. Intensive Care Med 2001; 27(suppl): abstract no 586: S285.
104. Hammond JMJ, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 1995;23:637-645.
105. Stoutenbeek CP, van Saene HKF, Zandstra DF. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 1987; 19: 513-520.
106. Leone M, Albanese J, Antonini F, et al. Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care multiple-trauma patients. Crit Care Med 2003; 31: 2090-2095.
107. Tetteroo GWM, Wagenvoort JHT, Bruining HA. Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother 1994; 34: 139-148.
108. Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002; 30: 391-399.
109. de la Cal MA, Cerda E, van Saene HKF et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004; March issue.
110. Bhorade SM, Christenson J, Pohlman AS, et al. The incidence of a clinical variables associated with vancomycin-resistant enterococcal colonisation in mechanically ventilated patients. Chest 1999; 115: 1085-1091.
111. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342: 1301-1308.
112. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
113. van den Berge G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Eng J Med 2001; 345: 1359-1367.
114. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fluorocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871.
115. Rommes JH, Rios G, Zandstra DF. Therapy of infection. Curr Anaesth Crit Care 2001; 12: 25-33.
116. Torres A, Aznar R, Gatell JM, et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 523-528.
117. Brown EM. Empirical antimicrobial therapy of mechanically ventilated patients with nosocomial pneumonia. J Antimicrob Chemother 1997; 40: 463-468.
118. Bergogne-Bérézin E. Treatment and prevention of nosocomial pneumonia. Chest 1995; 108: 26S-34S.
119. Clone LA, Woodward DR, Stolzman DS. Ceftazidime versus tobramycin/ticarcillin in the treatment of pneumonia and bacteremia. Antimicrob Agents Chemother 1985; 28: 33-36.
120. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Am J Respir Crit Care Med 1999; 159: 188-198.
121. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalised patients: results of a multicenter, randomised, double-blind trial comparing intravenous ciprofloxacin with imipenem/cilastin. Antimicrob Agents Chemother 1994; 38: 547-557.
122. Pennington JE. Approach to therapy of respiratory infections in the critical care setting. Sem Respir Infect 1990; 5: 226-232.
123. Palmer LB, Smaldone GC, Simon SR, et al. Aerolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 1998; 26: 31-39.
124. Brown RB, Kruse JA, Counts GW. Double-blind study of endotracheal tobramycin in the treatment of gram-negative pneumonia. Antimicrob Agents Chemother 1990; 34: 269-272.
125. A'Court CHD, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. QJM 1993;86:635-648.
126. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993; 147: 38-44.
127. Singh N, Rogers P, Atwood CW, et al. Short course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 2000; 162: 505-511.
128. Dennesen PJW, van der Ven AJAM, Kessels AGH, et al. Resolution of infections parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163: 1371-1375.
129. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29: 1109-1115.
130. Torres A, Serra-Battles J, Ferrer A, et al. Severe community-acquired pneumonia. Am Rev Respir Dis 1991; 144: 312-318.
131. Stoutenbeek CP, van Saene HKF, Miranda DR. Nosocomial gram-negative pneumonia in critically ill patients. Intensive Care Med 1986; 12: 419-423.
132. Hammond JMJ, Potgieter PD. Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU? Anaesth Intens Care 1995; 23: 168-174.